Filing Details
- Accession Number:
- 0001626199-21-000118
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-21 18:39:38
- Reporting Period:
- 2021-09-17
- Accepted Time:
- 2021-09-21 18:39:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1626199 | Alpine Immune Sciences Inc. | ALPN | Pharmaceutical Preparations (2834) | 208969493 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1736814 | Decheng Capital China Life Sciences Usd Fund Iii, L.p. | Ugland House, Po Box 309 Grand Cayman E9 KY1-1104 | No | No | Yes | No | |
| 1747821 | Decheng Capital Management Iii (Cayman), Llc | Ugland House, Po Box 309 Grand Cayman E9 KY1-1104 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-17 | 1,542,553 | $9.40 | 4,708,288 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reportable securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (the "Fund"). Decheng Capital Management III (Cayman), LLC (the "GP") is the general partner of the Fund. Xiangmin Cui is the manager of the GP. Each of the Fund, the GP and Dr. Cui may be deemed to beneficially own the securities held by the Fund. Each of the Fund, the GP and Dr. Cui disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interests therein.
Billionaire Hedge Funds
